Physician profile
Amanda C Phillips
NPI 1306257035
$5,420.10
in general payments reported to CMS, 2019-2025
20 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $430 · 2022: $817 · 2023: $807 · 2024: $2,304 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,920 · Travel and Lodging: $1,232 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,920.33 |
| Travel and Lodging | $1,231.80 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,606.77 | 2024 | Linq II, Venaseal |
| Abbott Laboratories | $1,313.10 | 2021-2025 | Aveir, Advisor, Coroflow |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $692.22 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $325.33 | 2022-2025 | Verquvo, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $240.76 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $240.18 | 2021-2025 | |
| Pfizer INC. | $208.89 | 2022-2025 | |
| Boston Scientific Corporation | $178.44 | 2024-2025 | Watchman Flx, Jetstream Sc, General - Therapies |
| Astrazeneca Pharmaceuticals LP | $102.36 | 2021-2024 | Farxiga |
| Vital Connect, INC | $95.43 | 2023-2024 | Vitalpatch Rtm |
| Janssen Pharmaceuticals, INC | $94.69 | 2021-2024 | Xarelto |
| Inspire Medical Systems, INC. | $92.76 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.38 | 2022 | |
| Sanofi-Aventis U.S. LLC | $38.03 | 2022 | |
| Alnylam Pharmaceuticals INC. | $35.61 | 2023 | Onpattro |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $34.91 | 2023-2024 | |
| Medicomp INC | $24.76 | 2022 | |
| Esperion Therapeutics, INC. | $15.97 | 2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $11.52 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $5.99 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.